UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • May

    14

    UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States

    Apr

    01

    UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star

    Mar

    27

    Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated diseases and HCPs

    Mar

    16

    3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time

    Mar

    10

    Innovation Equals Access: How UCB Delivered for Patients in 2025

    Feb

    04

    More than Medicine: UCB's Holistic Approach to Supporting MG Patients

    Dec

    03

    Bridging Strategy and Innovation: Leadership in Action through the AES BRIDGE Program

    Nov

    14

    When Every Second Matters

    Nov

    04

    Elevating the lives of people impacted by thymidine kinase 2 deficiency (TK2d)

    Oct

    31

    Redefining Hidradenitis Suppurativa (HS) Care Through Community and Collaboration